Alerts will be sent to your verified email
Verify EmailGUFICBIO
Gufic Biosciences
|
Orchid Pharma
|
Unichem Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.28 % | n/a | 5.35 % |
Financials
|
|||
5 yr Average ROE
|
16.89 % | 0.86 % | -0.79 % |
5yr average Equity Multiplier
|
2.16 | 1.61 | 1.32 |
5yr Average Asset Turnover Ratio
|
0.75 | 0.5 | 0.47 |
5yr Avg Net Profit Margin
|
10.24 % | 0.56 % | -1.68 % |
Price to Book
|
5.87 | 2.88 | 1.39 |
P/E
|
57.06 | 42.84 | 26.0 |
5yr Avg Cash Conversion Cycle
|
-15.25 Days | 52.03 Days | 88.84 Days |
Inventory Days
|
71.73 Days | 112.47 Days | 151.32 Days |
Days Receivable
|
106.89 Days | 86.58 Days | 122.86 Days |
Days Payable
|
179.29 Days | 159.29 Days | 205.05 Days |
5yr Average Interest Coverage Ratio
|
8.9 | 3.01 | 2.41 |
5yr Avg ROCE
|
17.89 % | 3.08 % | 1.04 % |
5yr Avg Operating Profit Margin
|
18.12 % | 11.84 % | 5.43 % |
5 yr average Debt to Equity
|
0.67 | 0.37 | 0.11 |
5yr CAGR Net Profit
|
-2.66 % | n/a | 32.0 % |
5yr Average Return on Assets
|
7.7 % | 1.2 % | -0.65 % |
Shareholdings
|
|||
Promoter Holding
|
72.52 % | 69.84 % | 70.22 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-2.48 % | -20.12 % | 19.29 % |
Change in Mutual Fund Holding (3 Yrs)
|
2.35 % | 16.13 % | 1.31 % |
Gufic Biosciences
|
Orchid Pharma
|
Unichem Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|